Anthranilamide inhibitors of factor Xa

被引：18

作者：

Mendel, David ^{[1
]}

Marquart, Angela L. ^{[1
]}

Joseph, Sajan ^{[1
]}

Waid, Philip ^{[1
]}

Yee, Ying K. ^{[1
]}

Tebbe, Anne Louise ^{[1
]}

Ratz, Andrew M. ^{[1
]}

Herron, David K. ^{[1
]}

Goodson, Theodore ^{[1
]}

Masters, John J. ^{[1
]}

Franciskovich, Jeffry B. ^{[1
]}

Tinsley, Jennifer M. ^{[1
]}

Wiley, Michael R. ^{[1
]}

Weir, Leonard C. ^{[1
]}

Kyle, Jeffrey A. ^{[1
]}

Klimkowski, Valentine J. ^{[1
]}

Smith, Gerald F. ^{[1
]}

Towner, Richard D. ^{[1
]}

Froelich, Larry L. ^{[1
]}

Buben, John ^{[1
]}

Craft, Trelia J. ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 17期

关键词：

protease inhibitor; factor Xa; anticoagulant;

D O I：

10.1016/j.bmcl.2007.06.051

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR about the B-ring of a series of N-2-aroyl anthranilamide factor Xa (tXa) inhibitors is described. B-ring o-aminoalkylether and B-ring p-amine probes of the S1' and S4 sites, respectively, afforded picomolar fXa inhibitors that performed well in in vitro anticoagulation assays. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：4832 / 4836

页数：5

共 50 条

[41] Isoxazolines and isoxazoles as factor Xa inhibitors.
Pruitt, JR
Pinto, DJ
Quan, ML
Estrella, MJ
Bostrom, LL
Knabb, RM
Wong, PC
Wexler, RR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U224 - U224
[42] Development of potent and selective factor Xa inhibitors
Rai, R
Kolesnikov, A
Li, Y
Young, WB
Leahy, E
Sprengeler, PA
Verner, E
Shrader, WD
Burgess-Henry, J
Sangalang, JC
Allen, D
Chen, X
Katz, BA
Luong, C
Elrod, K
Cregar, L
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1797 - 1800
[43] Synthetic direct and indirect factor Xa inhibitors
Samama, MM
THROMBOSIS RESEARCH, 2002, 106 (03) : V267 - V273
[44] From heparins to factor Xa inhibitors and beyond
Alban, S
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 : 12 - 20
[45] ANTICOAGULATION WITH SYNTHETIC FACTOR-XA INHIBITORS
TIDWELL, RR
GERATZ, JD
CIRCULATION, 1980, 62 (04) : 280 - 280
[46] Isoxazoline derivatives as potent factor Xa inhibitors
Pinto, DJP
Quan, ML
Fevig, JM
Pruitt, JR
Ellis, CD
Orwat, M
Wang, S
Liauw, AY
Wong, PC
Knabb, RM
Thoolen, MJ
Wexler, RR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U895 - U895
[47] Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors
Quan, ML
Ellis, CD
He, MY
Liauw, AY
Lam, PYS
Rossi, KA
Knabb, RM
Luettgen, JM
Wright, MR
Wong, PC
Wexler, RR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1023 - 1028
[48] Nonbenzamidine tetrazole derivatives as factor Xa inhibitors
Quan, ML
Ellis, CD
He, MY
Liauw, AY
Woerner, FJ
Alexander, RS
Knabb, RM
Lam, PYS
Luettgen, JM
Wong, PC
Wright, MR
Wexler, RR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 369 - 373
[49] Direct factor Xa inhibitors paradoxically prolong the half life of active factor Xa in plasma
Thalji, N.
Krishnaswamy, S.
Camire, R. M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 902 - 902
[50] Reversal of direct factor Xa inhibitors using factor Xa zymogen-like variants
Thalji, N.
Patel-Hett, S.
Fruebis, J.
Pittman, D.
Camire, R. M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 167 - 167

← 1 2 3 4 5 →